| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Maxim Shevtsov | Q59689890 |
| Gabriele Multhoff | Q47813083 | ||
| P2093 | author name string | Gabriele Multhoff | |
| Maxim Shevtsov | |||
| P2860 | cites work | Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages | Q24609722 |
| Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial | Q26858884 | ||
| The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition | Q27649331 | ||
| Emerging roles for scavenger receptor SREC-I in immunity | Q28080847 | ||
| Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function | Q28218547 | ||
| Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation | Q28646520 | ||
| Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody | Q30497901 | ||
| Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. | Q30967103 | ||
| A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients | Q33382497 | ||
| Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells | Q33604925 | ||
| Induction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice. | Q33730763 | ||
| Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children | Q33800747 | ||
| Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications | Q33899708 | ||
| Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses | Q34115645 | ||
| A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma | Q34617610 | ||
| Gene vaccines | Q35095112 | ||
| Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo | Q35154049 | ||
| A mouse tumor-specific transplantation antigen is a heat shock-related protein | Q35603985 | ||
| Tumor rejection antigens of chemically induced sarcomas of inbred mice | Q35605797 | ||
| Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. | Q35613124 | ||
| Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72 | Q35792444 | ||
| Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings | Q57570391 | ||
| A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides | Q60307732 | ||
| Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages | Q61893828 | ||
| Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells | Q61893852 | ||
| Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells | Q61893857 | ||
| A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells | Q61893867 | ||
| Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography | Q73457700 | ||
| HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine | Q73606601 | ||
| CD91: a receptor for heat shock protein gp96 | Q73615235 | ||
| Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer | Q73910273 | ||
| Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells | Q74183154 | ||
| Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells | Q74310288 | ||
| Induction of systemic antitumor immunity by gene transfer of mammalian heat shock protein 70.1 into tumors in situ | Q77462833 | ||
| A vaccine for renal cancer | Q79754768 | ||
| Therapeutic cancer vaccines | Q82495300 | ||
| Cancer immunology | Q95819282 | ||
| Heat shock protein-based cancer vaccines | Q35843630 | ||
| Role of membrane Hsp70 in radiation sensitivity of tumor cells | Q35879762 | ||
| Heat shock protein 70-associated peptides elicit specific cancer immunity | Q36362368 | ||
| The dual nature of specific immunological activity of tumor-derived gp96 preparations | Q36368193 | ||
| Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity | Q36380745 | ||
| The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. | Q36685564 | ||
| Human natural killer receptors, co-receptors, and their ligands. | Q37399014 | ||
| Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial | Q37492175 | ||
| Activating and inhibitory receptors of natural killer cells | Q37766751 | ||
| The role of heat shock proteins in antigen cross presentation | Q38008364 | ||
| Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy. | Q38120836 | ||
| Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents. | Q38199545 | ||
| Exogenously delivered heat shock protein 70 displaces its endogenous analogue and sensitizes cancer cells to lymphocytes-mediated cytotoxicity | Q38998531 | ||
| Investigating receptors for extracellular heat shock proteins | Q39478462 | ||
| Enhanced generation of cytotoxic T lymphocytes by heat shock protein 70 fusion proteins harboring both CD8(+) T cell and CD4(+) T cell epitopes | Q39669582 | ||
| T cell activation by heat shock protein 70 vaccine requires TLR signaling and scavenger receptor expressed by endothelial cells-1 | Q39819170 | ||
| Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells | Q39958463 | ||
| The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands | Q40073011 | ||
| Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells | Q40240250 | ||
| Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. | Q40357536 | ||
| Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells | Q40408986 | ||
| Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response | Q40425157 | ||
| Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. | Q40533110 | ||
| Heat shock proteins in immune response to cancer: the Fourth Paradigm | Q40648771 | ||
| Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. | Q40658554 | ||
| Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. | Q40691520 | ||
| CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes | Q40700550 | ||
| Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study | Q40746131 | ||
| HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway | Q40751242 | ||
| Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. | Q40751982 | ||
| Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. | Q40960957 | ||
| A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity | Q40969222 | ||
| Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens | Q41108048 | ||
| Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells | Q41114467 | ||
| Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial | Q41733152 | ||
| CD91-Dependent Modulation of Immune Responses by Heat Shock Proteins: A Role in Autoimmunity. | Q42283936 | ||
| CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin | Q43566795 | ||
| Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial. | Q44917998 | ||
| HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma | Q45855370 | ||
| Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group. | Q46748085 | ||
| Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis | Q47897499 | ||
| Plasma exosomes protect the myocardium from ischemia-reperfusion injury. | Q48674766 | ||
| What ASCO does for its members | Q49274143 | ||
| 70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma. | Q50698276 | ||
| Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma | Q51813573 | ||
| Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70. | Q55461040 | ||
| A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients | Q57570360 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 171 | |
| P577 | publication date | 2016-04-29 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of Cancer | |
| P478 | volume | 7 |
| Q47226956 | A comparison of cell survival and heat shock protein expression after radiation in normal dermal fibroblasts, microvascular endothelial cells, and different head and neck squamous carcinoma cell lines |
| Q48145688 | A comparison of two sources of methionine supplemented at different levels on heat shock protein 70 expression and oxidative stress product of Peking ducks subjected to heat stress. |
| Q91731105 | Advancements in Prophylactic and Therapeutic Nanovaccines |
| Q55291915 | Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity. |
| Q60909641 | Application of built-in adjuvants for epitope-based vaccines |
| Q37587724 | B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation |
| Q39451757 | Cancer immunotherapy: moving forward with peptide T cell vaccines |
| Q92837698 | Cloning, expression of a truncated HSP110 protein that augments the activities of tumor antigen-specific cytotoxic and apoptosis via tHSP110-peptide complex vaccines |
| Q90145195 | Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients |
| Q42328475 | Editorial: The HSP70 Molecular Chaperone Machines |
| Q38662422 | Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma. |
| Q58568805 | Heat Shock Proteins as Immunomodulants |
| Q55190074 | Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response. |
| Q52558324 | Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease. |
| Q87944374 | Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies |
| Q58729712 | Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy |
| Q39043413 | Immunotherapy of colorectal cancer: new perspectives after a long path. |
| Q64232509 | Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies |
| Q57179194 | Influence of hyperthermal regimes on experimental teratoma development in vitro |
| Q61798268 | Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma |
| Q64231695 | Membrane Hsp70-supported cell-to-cell connections via tunneling nanotubes revealed by live-cell STED nanoscopy |
| Q39370805 | Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years |
| Q61809072 | Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation |
| Q92487370 | Role of heat shock proteins in bladder cancer: potential biomarkers for treatment response and oncological prognosis |
| Q90417081 | T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment |
| Q41660505 | Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach |
| Q60907513 | The Autoantigenic Proinsulin B-Chain Peptide B11-23 Synergises with the 70 kDa Heat Shock Protein DnaK in Macrophage Stimulation |
| Q96304342 | The expression profiles and prognostic values of HSPs family members in Head and neck cancer |
| Q93018120 | Transcriptomic Analysis Provides Novel Insights into Heat Stress Responses in Sheep |
| Q39281019 | Unconventional Secretion of Heat Shock Proteins in Cancer |
| Q47583155 | Vaccination in the immunotherapy of glioblastoma |
Search more.